Evidence map›Paper›PMID 41460282›Full record

Trial reportAIDS and behavior2026

A Randomized Feasibility/Acceptability Trial of Acceptance and Commitment Therapy for People with HIV Who Drink at Unhealthy Levels.

Sarah E Woolf-King, Michelle R Dalton, Madison Firkey, Alan Sheinfil, Veronica Bucci, Brianna Estrada, Jeremy Ramos, Judith A Hahn, Jonathan Bricker, Brooks Gump and 2 more

Abstract readRandomized Controlled Trial
In one paragraph

Trial report in AIDS and behavior, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Sarah E Woolf-KingDepartment of Psychology, Syracuse University, Syracuse, NY, 13244, USA. sewoolf@syr.edu.ORCID http://orcid.org/0000-0002-5612-1114
Michelle R DaltonDepartment of Family and Community Medicine, St. Louis University, St. Louis, MO, USA.
Madison FirkeyDepartment of Psychiatry and Behavioral Sciences, SUNY Upstate Medical University, Syracuse, NY, USA.
Alan SheinfilSchool of Psychology and Counseling, Farleigh Dickinson University, Teaneck, NJ, USA.
Veronica BucciDepartment of Psychiatry, College of Medicine, University of Illinois Chicago, Chicago, IL, USA.
Brianna EstradaBehavioral Medicine Program, Massachusetts General Hospital, Boston, MA, USA.
Jeremy RamosDepartment of Psychiatry, University of Rochester, Rochester, NY, USA.
Judith A HahnDepartment of Medicine, University of California, San Francisco, CA, USA.
Jonathan BrickerFred Hutchinson Cancer Research Center, Seattle, WA, USA.
Brooks GumpDepartment of Public Health, Syracuse University, Syracuse, NY, USA.
Kestutis G BendinskasDepartment of Chemistry, State University of New York at Oswego, Oswego, NY, USA.
Stephen A MaistoDepartment of Psychology, Syracuse University, Syracuse, NY, 13244, USA.

Funding

Training in Research Program on Alcohol Use by Persons with our at Risk for HIVK24AA022586 · NIAAA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI HAHN, JUDITH ALISSA · 2013 to 2023
$1.8M
Brief Acceptance and Commitment Therapy for HIV-Infected At-Risk Drinkers Administrative SupplementR34AA026246 · NIAAA · SYRACUSE UNIVERSITY · PI MAISTO, STEPHEN A, WOOLF-KING, SARAH E · 2018 to 2021
$897k
NIAAA NIH HHS K24 AA022586NIAAA NIH HHS R34 AA026246NIAAA NIH HHS R34AA026246NIAAA NIH HHS R34AA026246-03S1
6 · The paper itself

Abstract

Unhealthy alcohol use is prevalent among people with HIV (PWH) and associated with significant health-related consequences. We describe here a randomized feasibility/acceptability trial of a brief, telephone-delivered transdiagnostic acceptance and commitment therapy (ACT) intervention for PWH who drink at unhealthy levels. This pilot trail was designed to match the procedures of a planned definitive RCT that will compare the ACT intervention to a brief alcohol intervention (BI). We randomly assigned PWH and unhealthy alcohol use 1:1 to either the ACT or the BI intervention and collected self-report and biomarker data post-treatment and again at 3-, 6-, and 12-months. The primary objectives of this pilot trial were to assess feasibility of recruitment, retention, and intervention delivery, and acceptability of intervention content. We also collected preliminary primary (alcohol use) and secondary (symptoms of anxiety, depression, and experiential avoidance) outcome data to examine general patterns of results at a purely descriptive level. In total, 192 participants were screened, 117 of whom were eligible, and 49 of whom were randomized to either the ACT (n = 24) or BI (n = 25) condition. Results provided evidence of feasibility and acceptability indicating that a definitive trial should proceed. Preliminary outcome data also suggested that ACT is a promising treatment for unhealthy alcohol use and co-morbid symptoms of depression, anxiety, and experiential avoidance. A definitive trial is currently underway and will determine the comparative efficacy of ACT versus BI for unhealthy alcohol use for PWH.

Indexed as

Acceptance and Commitment TherapyAlcohol DrinkingAlcoholismHIV InfectionsPatient Acceptance of Health CareAdultFeasibility StudiesFemaleHumansMaleMiddle AgedPilot ProjectsSelf ReportTelephoneTreatment OutcomeAcceptanceAlcoholHIVTransdiagnostic

Identifiers

PMID41460282
PMCPMC13303479

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.